Description
NSE notifies listing of further equity shares allotted under ESOP schemes for Aditya Birla Capital, AU Small Finance Bank, Bandhan Bank, Coforge, HDFC Bank, Jagsonpal Pharmaceuticals, and Vaswani Industries, effective April 27, 2026.
Summary
NSE has notified the listing of further equity shares admitted to dealings on the Capital Market segment with effect from April 27, 2026, for seven companies under Circular Ref. No. 0686/2026 (Download Ref. No. NSE/CML/73892). All new shares were allotted under respective Employee Stock Option Plans (ESOP) and carry full pari passu rights with existing equity shares. No lock-in restrictions apply to any of the allotments.
Key Points
- Seven companies have listed additional equity shares arising from ESOP allotments, all effective April 27, 2026
- All new securities rank pari passu with existing equity shares and carry no lock-in period
- Securities are identified by their existing NSE symbols and series codes; market lot is 1 for all
- Issued under NSE Capital Market Trading Regulations 3.1.1 (admission to dealings) and 2.5.5 (lot sizes)
- Vaswani Industries Limited is mentioned in the subject but detailed annexure data was not included in the available content
Regulatory Changes
No regulatory changes. This is a routine notification under existing NSE Capital Market Trading Regulations for the admission of further issued securities to dealings.
Compliance Requirements
No action required from members or market participants. The circular is informational — securities will be tradeable from April 27, 2026 using their existing designated codes.
Important Dates
| Event | Date |
|---|---|
| Circular Date | April 24, 2026 |
| Effective Date (Trading Commencement) | April 27, 2026 |
| ABCAPITAL ESOP Allotment Date | April 17, 2026 |
| AUBANK ESOP Allotment Date | April 22, 2026 |
| BANDHANBNK ESOP Allotment Date | April 13, 2026 |
| COFORGE ESOP Allotment Date | April 15, 2026 |
| HDFCBANK ESOP Allotment Date | April 22, 2026 |
| JAGSNPHARM ESOP Allotment Date | April 13, 2026 |
Impact Assessment
The combined ESOP allotments represent routine share capital increases across seven listed companies. The largest issuance by volume is HDFC Bank at 1,784,256 shares (ISIN: INE040A01034, face value Re. 1), followed by Jagsonpal Pharmaceuticals at 176,900 shares and Aditya Birla Capital at 101,835 shares. All allotments are small relative to total outstanding capital of the respective companies and are not expected to have any material price or liquidity impact. Existing shareholders experience marginal dilution consistent with ESOP disclosures already made by these companies.
| Symbol | ISIN | Face Value | Shares Allotted | Distinctive Numbers |
|---|---|---|---|---|
| ABCAPITAL | INE674K01013 | Rs. 10 | 1,01,835 | 2620420454–2620522288 |
| AUBANK | INE949L01017 | Rs. 10 | 91,668 | 748267122–748358789 |
| BANDHANBNK | INE545U01014 | Rs. 10 | 6,273 | 1610972315–1610978587 |
| COFORGE | INE591G01025 | Rs. 2 | 39,681 | 335810938–335850618 |
| HDFCBANK | INE040A01034 | Re. 1 | 17,84,256 | 16557994163–16559778418 |
| JAGSNPHARM | INE048B01035 | Rs. 2 | 1,76,900 | 66962251–67139150 |
Impact Justification
Routine ESOP-based further issue listing notification. All allotments are pari passu with no lock-in and involve relatively small quantities compared to total outstanding shares. HDFC Bank's 1.78 lakh shares is the largest absolute issuance but immaterial relative to its market cap. No regulatory changes or compliance obligations for market participants.